In addition, studies have reported that nuclear pore density increases in senescent cells [20], and nucleoporins such as TPR accumulate after treatment of HDAC inhibitors in the nucleus of cancer cells [22], resulting in the secretion of SASP. Here, HDAC9 is linked to cancer.